ImageneBio Inc

IMA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$49,234-$68,166-$68,765-$34,115
Dep. & Amort.$490$1,020$751$544
Deferred Tax$0$0$0$0
Stock-Based Comp.$5,295$0$7,525$5,177
Change in WC-$3,979-$21,669-$15,138-$33,032
Other Non-Cash$1,424$9,072$1,518$1,174
Operating Cash Flow-$46,004-$79,743-$74,109-$60,252
Investing Activities
PP&E Inv.$0-$414-$1,431-$1,760
Net Acquisitions$0$0$0$0
Inv. Purchases-$88,298-$90,052-$216,338$0
Inv. Sales/Matur.$60,460$154,610$118,485$0
Other Inv. Act.-$7,065$0$0$0
Investing Cash Flow-$34,903$64,144-$99,284-$1,760
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$37,557$0$131,302
Stock Repurch.$0-$663$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$39,086$1,095$436
Financing Cash Flow$0$75,980$1,095$131,738
Forex Effect$0-$406$0$0
Net Chg. in Cash-$80,907$59,975-$172,298$69,726
Supplemental Information
Beg. Cash$121,172$59,919$233,089$163,363
End Cash$40,265$119,894$60,791$233,089
Free Cash Flow-$46,004-$80,157-$75,540-$62,012
ImageneBio Inc (IMA) Financial Statements & Key Stats | AlphaPilot